Inthera Bioscience
Develops small molecular therapies for solid tumours
Inthera Bioscience has raised €3.5M across 1 funding round from 1 investor, most recently a Seed round in Dec 2015. Based in Zurich, Switzerland; founded 2013; active in Healthtech. Data as of 28 Oct 2026.
Zurich, SwitzerlandFounded 2013
Total raised
€3.5M
€3,497,495
Funding rounds
1
Investors
1
distinct backers
Active since
2015-12
latest 2015-12
Funding by year
EUR raised per yearInthera Bioscience — funding by year — interactive chart.
Data table
| Inthera Bioscience — funding by year | |
|---|---|
| 2015 | €3.5M |
Signals
High confidenceRaise-next likelihood8
base rate 44% for Seed
- ▼ Dormant (no round in 3+ cohort gaps)
- ▼ Low backer re-investment
Timing: dormant vs cohort gap · momentum unknown. Funding-only estimates, not predictions and not investment advice — see signals.
Funding rounds
1 round| Date | Stage | Amount | Investors | |
|---|---|---|---|---|
| 2015-12-01 | Seed | €3.5M | Aglaia Biomedical Ventures | View deal → |
Investors
1Similar companies
same sector or country- Philips€2.6BNetherlands · Healthtech
- Isomorphic Labs€2.3BUK · Healthtech
- CMR Surgical€1.5BUK · Healthtech
- Roivant Sciences€1.1BSwitzerland · Healthtech
- Neko Health€924MSweden · Healthtech
- Climeworks€919MSwitzerland · Cleantech
Global coverage: FundingData